Updated Jul 16, 2026
Khara Rahul has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $1.47M.

Rahul Khara is the Chief Legal Officer of Disc Medicine, Inc., a clinical-stage biopharmaceutical company focused on hematologic diseases. In the SEC filing dated 2026-01-06, he is listed as Chief Legal Officer with no reported stock purchases or sales, highlighting his role in governance, compliance, and strategic legal matters for the company.
| Role | Insider |
|---|---|
| Notability | 40/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-30 | IRON | Disc Medicine, Inc. | S — Open-market sale | 1.6K | $75.00 | $124K |
| 2026-06-30 | IRON | Disc Medicine, Inc. | M — Option exercise | 1.6K | $14.69 | $24K |
| 2026-06-30 | IRON | Disc Medicine, Inc. | S — Open-market sale | 851 | $75.00 | $64K |
| 2026-06-30 | IRON | Disc Medicine, Inc. | M — Option exercise | 851 | $14.69 | $13K |
| 2026-06-23 | IRON | Disc Medicine, Inc. | S — Open-market sale | 500 | $71.62 | $36K |
| 2026-06-23 | IRON | Disc Medicine, Inc. | S — Open-market sale | 1.6K | $70.73 | $113K |
| 2026-06-23 | IRON | Disc Medicine, Inc. | S — Open-market sale | 5.4K | $69.94 | $378K |
| 2026-06-23 | IRON | Disc Medicine, Inc. | M — Option exercise | 7.5K | $14.69 | $110K |
| 2026-02-18 | IRON | Disc Medicine, Inc. | S — Open-market sale | 2.9K | $62.86 | $179K |
| 2026-02-12 | IRON | Disc Medicine, Inc. | A — Grant or award | 17.0K | $0.00 | |
| 2026-01-21 | IRON | Disc Medicine, Inc. | S — Open-market sale [10b5-1] | 1.0K | $69.74 | $70K |
| 2026-01-21 | IRON | Disc Medicine, Inc. | M — Option exercise [10b5-1] | 1.0K | $13.50 | $14K |
| 2026-01-06 | IRON | Disc Medicine, Inc. | S — Open-market sale [10b5-1] | 1.2K | $79.27 | $92K |
| 2026-01-06 | IRON | Disc Medicine, Inc. | S — Open-market sale [10b5-1] | 5.0K | $78.62 | $393K |
| 2026-01-06 | IRON | Disc Medicine, Inc. | S — Open-market sale [10b5-1] | 350 | $77.67 | $27K |
| 2026-01-06 | IRON | Disc Medicine, Inc. | M — Option exercise [10b5-1] | 6.5K | $13.50 | $88K |
Rahul Khara is the Chief Legal Officer of Disc Medicine, Inc., a clinical-stage biopharmaceutical company focused on hematologic diseases. In the SEC filing dated 2026-01-06, he is listed as Chief Legal Officer with no reported stock purchases or sales, highlighting his role in governance, compliance, and strategic legal matters for the company.…
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 10 open-market sales ($1.47M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Khara Rahul profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.